marketcaparena
Search

    AORT

    ARTIVION, INC.

    Company overview

    Market capitalization
    $1.12B
    Employees
    1,800
    Latest publication
    2026-09-29
    About ARTIVION, INC.

    Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue125,757,000USD116,337,000USD115,992,000USD113,388,000USD112,972,000USD98,978,000USD97,308,000USD95,779,000USD
    Cost Of Revenue45,240,000USD44,800,000USD46,333,000USD38,993,000USD39,860,000USD35,401,000USD35,806,000USD34,770,000USD
    Gross Profit80,517,000USD71,537,000USD69,659,000USD74,395,000USD73,112,000USD63,577,000USD61,502,000USD61,009,000USD
    Research Development9,055,000USD8,841,000USD9,122,000USD8,077,999USD7,063,000USD6,728,000USD7,404,000USD6,605,000USD
    Selling General Administrative79,826,000USD60,820,000USD56,841,000USD57,281,000USD57,665,000USD54,704,000USD40,047,000USD43,095,000USD
    Total Operating Expenses88,881,000USD64,050,000USD62,479,000USD61,859,000USD64,728,000USD61,432,000USD58,833,000USD56,622,000USD
    Operating Income-8,364,000USD7,487,000USD7,180,000USD12,536,000USD8,384,000USD2,145,000USD2,669,000USD4,387,000USD
    Total Other Income Expense Net-3,335,000USD-7,148,000USD-643,000USD-5,480,000USD-4,902,000USD-4,440,000USD-19,271,000USD-5,653,000USD
    Interest Income367,000USD205,000USD311,000USD240,000USD68,000USD144,000USD374,000USD366,000USD
    Interest Expense7,253,000USD5,367,000USD5,530,000USD6,119,000USD7,270,000USD7,663,000USD9,742,000USD8,405,000USD
    Income Before Tax-11,699,000USD339,000USD6,537,000USD7,056,000USD3,482,000USD-2,295,000USD-16,602,000USD-1,266,000USD
    Income Tax Expense1,811,000USD-1,078,000USD4,111,000USD554,000USD2,137,000USD-1,790,000USD-119,000USD1,022,000USD
    Net Income-13,510,000USD1,417,000USD2,426,000USD6,502,000USD1,345,000USD-505,000USD-16,483,000USD-2,288,000USD
    Net Income Applicable To Common Shares-13,494,000USD———————
    Unclassified Operating Expenses—-5,611,000USD-3,484,000USD-3,499,999USD——1,182,000USD3,522,000USD
    Net Interest Income—-5,162,000USD-5,219,000USD-5,879,000USD-7,202,000USD-7,519,000USD-9,368,000USD-8,039,000USD
    Tax Provision—-1,078,000USD4,111,000USD554,000USD2,137,000USD-1,790,000USD-119,000USD1,022,000USD
    Net Income From Continuing Ops—1,417,000USD2,426,000USD6,502,000USD1,345,000USD-505,000USD-16,483,000USD-2,288,000USD
    Ebit—5,706,000USD12,067,000USD13,175,000USD10,752,000USD5,368,000USD-6,860,000USD7,139,000USD
    Ebitda—12,046,000USD17,824,000USD18,892,000USD16,290,000USD10,814,000USD-565,000USD13,249,000USD
    Depreciation And Amortization—6,340,000USD5,757,000USD5,717,000USD5,538,000USD5,446,000USD6,295,000USD6,110,000USD
    Reconciled Depreciation—6,340,000USD5,757,000USD5,717,000USD5,538,000USD5,446,000USD6,295,000USD6,110,000USD
    Selling And Marketing Expenses——————10,200,000USD3,400,000USD
    Source0001628280-26-054746DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue441,330,000USD388,537,000USD354,004,000USD313,789,000USD298,836,000USD253,227,000USD276,222,000USD262,841,000USD
    Cost Of Revenue170,878,000USD139,756,000USD124,828,000USD111,266,000USD101,322,000USD85,443,000USD93,209,000USD89,857,000USD
    Gross Profit270,452,000USD248,781,000USD229,176,000USD202,523,000USD197,514,000USD167,784,000USD183,013,000USD172,984,000USD
    Research Development30,991,000USD28,452,000USD28,707,000USD38,879,000USD35,546,000USD24,207,000USD22,960,000USD23,098,000USD
    Selling General Administrative226,491,000USD190,676,000USD183,503,000USD164,754,000USD168,774,000USD140,036,000USD143,011,000USD140,574,000USD
    Unclassified Operating Expenses-13,775,000USD-9,221,000USD9,324,000USD-7,311,000USD-14,923,000USD———
    Total Operating Expenses243,707,000USD209,907,000USD223,434,000USD196,322,000USD189,397,000USD165,343,000USD165,971,000USD163,672,000USD
    Operating Income26,745,000USD38,874,000USD5,742,000USD6,201,000USD8,117,000USD2,441,000USD17,042,000USD9,312,000USD
    Interest Income763,000USD1,467,000USD740,000USD147,000USD79,000USD217,000USD738,000USD226,000USD
    Interest Expense26,582,000USD34,277,000USD25,299,000USD18,224,000USD16,887,000USD16,698,000USD14,886,000USD15,788,000USD
    Net Interest Income-25,819,000USD-32,810,000USD-23,685,000USD-18,077,000USD-16,808,000USD-16,481,000USD-14,148,000USD-15,562,000USD
    Income Before Tax14,780,000USD-7,514,000USD-21,586,000USD-14,984,000USD-14,827,000USD-17,174,000USD1,644,000USD-6,391,000USD
    Income Tax Expense5,012,000USD5,845,000USD9,104,000USD4,208,000USD7,000USD-492,000USD-76,000USD-2,586,000USD
    Tax Provision5,012,000USD5,845,000USD6,828,000USD4,208,000USD7,000USD-492,000USD-76,000USD-3,551,000USD
    Net Income9,768,000USD-13,359,000USD-30,690,000USD-19,192,000USD-14,834,000USD-16,682,000USD1,720,000USD-3,805,000USD
    Net Income From Continuing Ops9,768,000USD-13,359,000USD-24,546,000USD-19,192,000USD-14,834,000USD-16,682,000USD1,720,000USD-2,840,000USD
    Ebit41,362,000USD26,763,000USD3,713,000USD3,240,000USD2,060,000USD-476,000USD16,530,000USD12,112,000USD
    Ebitda63,820,000USD50,968,000USD26,789,000USD25,682,000USD26,037,000USD20,236,000USD34,847,000USD30,207,000USD
    Depreciation And Amortization22,458,000USD24,205,000USD23,076,000USD22,442,000USD23,977,000USD20,712,000USD18,317,000USD18,095,000USD
    Reconciled Depreciation22,458,000USD24,205,000USD22,686,000USD22,442,000USD23,977,000USD20,712,000USD18,317,000USD18,095,000USD
    Total Other Income Expense Net-11,965,000USD-46,388,000USD-27,328,000USD-21,185,000USD-22,944,000USD-19,615,000USD-15,398,000USD-15,703,000USD
    Selling And Marketing Expenses——1,900,000USD——1,100,000USD—732,000USD
    Non Operating Income Net Other———-2,961,000USD-6,057,000USD———
    Net Income Applicable To Common Shares———-19,192,000USD-14,834,000USD-16,571,000USD1,708,000USD-2,813,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,071,934,000USD883,157,000USD884,796,000USD857,662,000USD838,387,000USD791,163,000USD789,101,000USD803,144,000USD
    Cash And Equivalents77,316,000USD———————
    Total Current Assets371,380,000USD304,104,000USD303,551,000USD283,787,000USD318,820,000USD287,297,000USD290,080,000USD287,958,000USD
    Other Current Assets26,572,000USD44,725,000USD42,537,000USD22,445,000USD77,371,000USD71,919,000USD70,958,000USD69,688,000USD
    Other Non Current Assets15,227,000USD———————
    Total Liabilities626,349,000USD———————
    Total Current Liabilities106,931,000USD92,700,000USD101,556,000USD85,836,000USD66,670,000USD51,940,000USD66,823,000USD152,838,000USD
    Other Current Liabilities7,401,000USD———————
    Other Non Current Liabilities9,229,000USD———————
    Total Stockholder Equity445,585,000USD450,467,000USD448,232,000USD438,694,000USD419,902,000USD294,252,000USD276,200,000USD304,739,000USD
    Total Equity Including Noncontrolling Interest445,585,000USD———————
    Short Long Term Debt0USD———73,000USD135,000USD195,000USD99,698,000USD
    Long Term Debt363,423,000USD215,352,000USD215,114,000USD214,869,000USD215,538,000USD314,611,000USD314,152,000USD214,270,000USD
    Net Receivables97,928,000USD105,620,000USD103,679,000USD97,369,000USD101,250,000USD95,758,000USD85,893,000USD77,974,000USD
    Inventory103,364,000USD97,995,000USD92,427,000USD90,547,000USD86,723,000USD81,927,000USD79,766,000USD84,123,000USD
    Property Plant Equipment Net110,279,000USD102,299,000USD99,689,000USD79,594,000USD79,776,000USD77,039,000USD76,129,000USD79,468,000USD
    Goodwill349,862,000USD———————
    Accounts Payable20,870,000USD18,337,000USD16,042,000USD16,495,999USD19,426,000USD11,695,000USD17,971,000USD11,146,000USD
    Short Term Debt5,058,000USD5,529,000USD5,375,000USD5,798,000USD5,739,000USD5,379,000USD5,285,000USD104,211,000USD
    Common Stock502,000USD500,000USD493,000USD488,000USD486,000USD442,000USD434,000USD434,000USD
    Retained Earnings-63,591,000USD-50,081,000USD-51,498,000USD-53,924,000USD-60,426,000USD-61,771,000USD-61,266,000USD-44,783,000USD
    Accumulated Other Comprehensive Income-12,476,000USD-11,565,000USD-2,719,000USD-2,287,000USD-2,828,000USD-18,596,000USD-24,927,000USD-9,528,000USD
    Intangible Assets—154,887,000USD156,495,000USD156,833,000USD158,440,000USD151,925,000USD156,383,000USD164,579,000USD
    Total Liab—432,690,000USD436,564,000USD418,968,000USD418,485,000USD496,911,000USD512,901,000USD498,405,000USD
    Other Current Liab—61,704,000USD72,650,000USD63,542,001USD38,656,000USD33,261,000USD40,633,000USD33,960,000USD
    Capital Stock—500,000USD493,000USD488,000USD486,000USD442,000USD434,000USD434,000USD
    Good Will—251,660,000USD254,091,000USD254,004,000USD253,802,000USD245,069,000USD240,958,000USD248,745,000USD
    Cash—55,764,000USD64,908,000USD73,426,000USD53,476,000USD37,693,000USD53,463,000USD56,173,000USD
    Cash And Short Term Investments—55,764,000USD64,908,000USD73,426,000USD53,476,000USD37,693,000USD53,463,000USD56,173,000USD
    Net Debt—202,393,000USD227,133,000USD227,005,000USD210,265,000USD324,666,000USD308,795,000USD306,942,000USD
    Short Long Term Debt Total—258,157,000USD292,041,000USD300,431,000USD263,741,000USD362,359,000USD362,258,000USD363,115,000USD
    Property Plant Equipment Gross—102,299,000USD197,533,000USD79,594,000USD79,776,000USD77,039,000USD165,297,000USD79,468,000USD
    Common Stock Shares Outstanding—49,731,000shares49,601,000shares48,775,000shares45,378,000shares42,232,000shares41,882,000shares41,844,000shares
    Non Current Assets Total—579,053,000USD581,245,000USD573,875,000USD519,567,000USD499,744,000USD499,021,000USD515,186,000USD
    Non Current Liabilities Total—339,990,000USD335,008,000USD333,132,000USD351,815,000USD444,971,000USD446,078,000USD345,567,000USD
    Non Current Liabilities Other—49,987,000USD48,997,000USD45,818,000USD61,628,000USD58,389,000USD60,945,000USD60,195,000USD
    Non Currrent Assets Other—69,068,000USD69,769,000USD82,843,000USD26,856,000USD25,027,000USD24,483,000USD20,936,000USD
    Net Working Capital—264,816,000USD256,526,000USD251,662,000USD252,150,000USD235,357,000USD223,257,000USD135,120,000USD
    Unclassified Current Liabilities—7,130,000USD7,489,000USD—2,776,000USD1,470,000USD2,739,000USD-99,698,000USD
    Unclassified Non Current Liabilities—74,651,000USD70,897,000USD72,445,000USD74,649,000USD71,971,000USD70,981,000USD71,102,000USD
    Unclassified Equity—511,113,000USD501,463,000USD493,929,000USD482,184,000USD373,735,000USD361,525,000USD358,182,000USD
    Other Assets—————4,122,000USD——
    Current Deferred Revenue———————3,521,000USD
    Source0001628280-26-054746DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets884,796,000USD789,101,000USD792,397,000USD762,798,000USD793,052,000USD789,404,000USD605,654,000USD571,091,000USD
    Intangible Assets156,495,000USD156,383,000USD172,231,000USD182,647,000USD201,496,000USD227,057,000USD157,734,000USD160,081,000USD
    Other Current Assets42,537,000USD70,958,000USD65,614,000USD63,921,000USD57,611,000USD51,387,000USD44,692,000USD40,769,000USD
    Total Liab436,564,000USD512,901,000USD510,617,000USD478,469,000USD492,324,000USD460,691,000USD319,958,000USD296,024,000USD
    Total Stockholder Equity448,232,000USD276,200,000USD281,780,000USD284,329,000USD300,728,000USD328,713,000USD285,696,000USD275,067,000USD
    Other Current Liab80,139,000USD40,633,000USD35,276,000USD29,607,000USD25,617,000USD40,465,000USD25,167,000USD22,108,000USD
    Common Stock493,000USD434,000USD426,000USD418,000USD414,000USD404,000USD390,000USD385,000USD
    Capital Stock493,000USD434,000USD426,000USD418,000USD414,000USD404,000USD390,000USD385,000USD
    Retained Earnings-51,498,000USD-61,266,000USD-47,907,000USD-17,217,000USD1,975,000USD20,022,000USD36,704,000USD34,984,000USD
    Good Will254,091,000USD240,958,000USD247,337,000USD243,631,000USD250,000,000USD260,061,000USD186,697,000USD188,781,000USD
    Cash64,908,000USD53,463,000USD58,940,000USD39,351,000USD55,010,000USD61,412,000USD33,766,000USD41,489,000USD
    Cash And Short Term Investments64,908,000USD53,463,000USD58,940,000USD39,351,000USD55,010,000USD61,412,000USD33,766,000USD41,489,000USD
    Total Current Assets303,551,000USD290,080,000USD280,668,000USD247,334,000USD247,697,000USD234,589,000USD187,390,000USD179,168,000USD
    Total Current Liabilities101,556,000USD66,823,000USD57,862,000USD49,675,000USD44,953,000USD60,468,000USD45,195,000USD34,523,000USD
    Net Debt227,133,000USD308,795,000USD299,401,000USD317,478,000USD307,033,000USD255,962,000USD211,386,000USD182,058,000USD
    Short Term Debt5,375,000USD5,285,000USD5,428,000USD5,429,000USD5,307,000USD7,572,000USD7,248,000USD2,618,000USD
    Short Long Term Debt Total292,041,000USD362,258,000USD358,341,000USD356,829,000USD362,043,000USD317,374,000USD245,152,000USD223,547,000USD
    Long Term Debt215,114,000USD314,152,000USD305,531,000USD306,499,000USD307,493,000USD290,468,000USD214,571,000USD215,721,000USD
    Net Receivables103,679,000USD85,893,000USD74,138,000USD69,584,000USD58,105,000USD48,752,000USD55,861,000USD51,432,000USD
    Inventory92,427,000USD79,766,000USD81,976,000USD74,478,000USD76,971,000USD73,038,000USD53,071,000USD45,478,000USD
    Accounts Payable16,042,000USD17,971,000USD13,318,000USD12,004,000USD10,395,000USD9,623,000USD9,796,000USD7,547,000USD
    Property Plant Equipment Net99,689,000USD76,129,000USD82,180,000USD80,533,000USD83,235,000USD51,648,000USD54,144,000USD31,028,000USD
    Property Plant Equipment Gross197,533,000USD165,297,000USD167,102,000USD80,533,000USD83,235,000USD138,825,000USD130,101,000USD—
    Accumulated Other Comprehensive Income-2,719,000USD-24,927,000USD-12,010,000USD-21,609,000USD-9,887,000USD6,743,000USD-8,589,000USD-6,072,000USD
    Common Stock Shares Outstanding47,162,000shares41,676,000shares40,743,000shares40,032,000shares38,983,000shares37,861,000shares37,860,000shares36,412,000shares
    Non Current Assets Total581,245,000USD499,021,000USD511,729,000USD515,464,000USD545,355,000USD554,815,000USD418,264,000USD391,923,000USD
    Non Current Liabilities Total335,008,000USD446,078,000USD452,755,000USD428,794,000USD447,371,000USD400,223,000USD274,763,000USD261,501,000USD
    Non Current Liabilities Other48,997,000USD60,945,000USD71,231,000USD47,427,000USD55,884,000USD50,190,000USD6,581,000USD6,869,000USD
    Non Currrent Assets Other69,769,000USD24,483,000USD8,894,000USD7,339,000USD8,267,000USD14,603,000USD14,208,000USD7,922,000USD
    Net Working Capital256,526,000USD223,257,000USD222,806,000USD197,659,000USD202,744,000USD174,121,000USD142,195,000USD144,645,000USD
    Unclassified Non Current Liabilities70,897,000USD70,981,000USD75,993,000USD-32,493,000USD-41,392,000USD-30,856,000USD16,752,000USD—
    Unclassified Equity501,463,000USD361,525,000USD340,845,000USD322,319,000USD307,812,000USD301,140,000USD256,801,000USD245,385,000USD
    Short Long Term Debt—195,000USD1,451,000USD1,608,000USD1,630,000USD1,195,000USD1,164,000USD1,160,000USD
    Unclassified Current Liabilities—2,739,000USD-1,451,000USD-23,472,000USD-26,169,000USD-33,100,000USD-24,024,000USD-1,160,000USD
    Current Deferred Revenue——3,840,000USD24,499,000USD28,173,000USD34,713,000USD25,844,000USD2,250,000USD
    Deferred Long Term Liab———29,967,000USD34,751,000USD———
    Other Liab———77,394,000USD90,635,000USD90,421,000USD36,859,000USD39,843,000USD
    Other Assets———8,653,000USD10,624,000USD16,049,000USD19,689,000USD12,033,000USD
    Net Tangible Assets———-141,949,000USD-150,768,000USD-158,405,000USD-58,735,000USD-73,795,000USD
    Unclassified Non Current Assets———-7,339,000USD-8,267,000USD-14,603,000USD-14,208,000USD-7,922,000USD
    Short Term Investments—————546,000USD528,000USD747,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation13,088,000USD
    Stock Based Compensation16,578,000USD
    Deferred Income Tax-1,421,000USD
    Change To Liabilities-4,370,000USD
    Change In Working Capital-9,641,000USD
    Operating Cash Flow-112,000USD
    Capital Expenditures-18,751,000USD
    Other Investing Activities-113,661,000USD
    Unclassified Investing Cash Flow-7,500,000USD
    Investing Cash Flow-139,912,000USD
    Net Debt Issuance147,435,000USD
    Other Financing Activities-426,000USD
    Unclassified Financing Cash Flow5,842,000USD
    Financing Cash Flow152,851,000USD
    Effect Of Forex Changes On Cash-419,000USD
    Change In Cash12,408,000USD
    End Cash Flow77,316,000USD
    Source0001628280-26-054746DeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income1,417,000USD2,426,000USD6,502,000USD1,343,000USD-505,000USD-16,483,000USD-2,285,000USD-2,121,000USD
    Depreciation6,340,000USD5,757,000USD5,717,000USD5,538,000USD5,446,000USD6,295,000USD6,110,000USD5,891,000USD
    Stock Based Compensation8,414,000USD4,083,000USD6,135,000USD10,927,000USD8,045,000USD2,743,000USD5,383,000USD4,252,000USD
    Other Non Cash Items4,636,000USD7,634,000USD6,307,000USD9,227,000USD-3,183,000USD14,009,000USD11,087,000USD5,086,000USD
    Change To Account Receivables-2,760,000USD-6,345,000USD8,736,000USD-1,738,000USD-7,922,000USD-12,039,000USD3,090,000USD-3,112,000USD
    Change To Inventory-6,379,000USD-3,714,000USD-6,042,000USD-3,068,000USD-2,453,000USD-1,346,000USD-2,626,000USD-785,000USD
    Change In Working Capital-19,129,000USD2,222,000USD3,239,000USD-866,000USD-26,756,000USD899,000USD1,724,000USD-3,668,000USD
    Total Cash From Operating Activities1,154,000USD19,560,000USD20,512,000USD15,011,000USD-16,953,000USD10,139,000USD11,455,000USD6,135,000USD
    Capital Expenditures-8,003,000USD-27,507,000USD-4,609,000USD-3,287,000USD-3,638,000USD-1,425,000USD-3,639,000USD-2,513,000USD
    Free Cash Flow-6,849,000USD-7,947,000USD15,903,000USD11,724,000USD-20,591,000USD8,714,000USD7,816,000USD3,622,000USD
    Total Cashflows From Investing Activities-10,503,000USD-30,507,000USD-4,609,000USD-3,287,000USD-3,638,000USD-11,425,000USD-10,639,000USD-2,513,000USD
    Net Borrowings-577,000USD-858,000USD-914,000USD-622,000USD-66,000USD-7,566,000USD-77,000USD—
    Total Cash From Financing Activities463,000USD2,430,000USD4,067,000USD2,598,000USD3,937,000USD174,000USD1,473,000USD-181,000USD
    Change In Cash-9,144,000USD-8,518,000USD19,950,000USD15,783,000USD-15,770,000USD-2,710,000USD1,154,000USD3,901,000USD
    Begin Period Cash Flow64,908,000USD73,426,000USD53,476,000USD37,693,000USD53,463,000USD56,173,000USD55,019,000USD51,118,000USD
    End Period Cash Flow55,764,000USD64,908,000USD73,426,000USD53,476,000USD37,693,000USD53,463,000USD56,173,000USD55,019,000USD
    Other Cashflows From Investing Activities-2,500,000USD-3,000,000USD—1,071,000USD—-10,000,000USD-7,000,000USD-2,513,000USD
    Other Cashflows From Financing Activities-210,000USD-173,000USD-3,290,000USD2,942,000USD-178,000USD7,297,000USD-148,000USD-179,000USD
    Unclassified Financing Cash Flow1,250,000USD3,461,000USD8,271,000USD—4,181,000USD—1,615,000USD—
    Unclassified Operating Cash Flow—-2,562,000USD-7,388,000USD-11,158,000USD—2,676,000USD-10,564,000USD-3,305,000USD
    Investments——-4,609,000USD-3,287,000USD-3,638,000USD-11,425,000USD-10,639,000USD-2,513,000USD
    Unclassified Investing Cash Flow——4,609,000USD2,216,000USD3,638,000USD11,425,000USD10,639,000USD5,026,000USD
    Sale Purchase Of Stock———16,000USD——83,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income9,768,000USD-13,359,000USD-30,690,000USD-19,192,000USD-14,834,000USD1,720,000USD-2,840,000USD3,704,000USD
    Depreciation22,458,000USD24,205,000USD23,076,000USD22,442,000USD23,977,000USD18,317,000USD18,095,000USD9,745,000USD
    Stock Based Compensation24,385,000USD14,242,000USD14,422,000USD12,344,000USD10,711,000USD8,799,000USD6,325,000USD6,919,000USD
    Other Non Cash Items3,643,000USD15,902,000USD29,595,000USD6,906,000USD15,263,000USD8,679,000USD2,798,000USD2,786,000USD
    Change To Account Receivables-7,269,000USD-15,395,000USD-4,050,000USD-13,340,000USD-11,560,000USD-3,384,000USD-5,910,000USD-7,258,000USD
    Change To Inventory-15,277,000USD-6,137,000USD-14,360,000USD-8,404,000USD-18,375,000USD-8,125,000USD2,384,000USD-9,369,000USD
    Change In Working Capital-22,161,000USD-17,243,000USD-16,193,000USD-25,936,000USD-33,232,000USD-19,383,000USD-10,012,000USD-10,868,000USD
    Total Cash From Operating Activities38,130,000USD22,236,000USD18,825,000USD-5,153,000USD-2,585,000USD15,827,000USD9,881,000USD10,803,000USD
    Capital Expenditures-39,041,000USD-11,188,000USD-7,430,000USD-10,715,000USD-13,091,000USD-8,072,000USD-5,786,000USD-7,041,000USD
    Free Cash Flow-911,000USD11,048,000USD11,395,000USD-15,868,000USD-15,676,000USD7,755,000USD4,095,000USD3,762,000USD
    Total Cashflows From Investing Activities-42,041,000USD-28,188,000USD-502,000USD-10,715,000USD5,660,000USD-23,943,000USD-6,715,000USD-170,992,000USD
    Net Borrowings-2,460,000USD-358,000USD-5,303,000USD-2,753,000USD-3,085,000USD-2,780,000USD-2,790,000USD152,787,000USD
    Total Cash From Financing Activities13,032,000USD2,203,000USD865,000USD-1,639,000USD-12,223,000USD-1,493,000USD-2,562,000USD143,245,000USD
    Sale Purchase Of Stock0USD0USD-559,000USD-1,795,000USD-1,914,000USD-2,743,000USD-2,100,000USD-1,614,000USD
    Change In Cash11,445,000USD-5,477,000USD19,589,000USD-15,659,000USD-6,948,000USD-7,942,000USD1,483,000USD-16,665,000USD
    Begin Period Cash Flow53,463,000USD58,940,000USD39,351,000USD55,010,000USD61,958,000USD42,236,000USD40,753,000USD56,642,000USD
    End Period Cash Flow64,908,000USD53,463,000USD58,940,000USD39,351,000USD55,010,000USD34,294,000USD42,236,000USD39,977,000USD
    Other Cashflows From Investing Activities-3,000,000USD-17,000,000USD6,928,000USD-1,699,000USD-249,000USD-15,871,000USD-929,000USD-86,000USD
    Other Cashflows From Financing Activities2,418,000USD-3,167,000USD4,196,000USD2,909,000USD-7,224,000USD4,030,000USD2,328,000USD-7,928,000USD
    Unclassified Financing Cash Flow13,074,000USD5,728,000USD2,531,000USD—3,756,000USD4,758,000USD——
    Investments—-28,188,000USD-501,000USD-10,715,000USD5,660,000USD-23,943,000USD-6,715,000USD—
    Unclassified Operating Cash Flow—-1,511,000USD-1,385,000USD-1,717,000USD-4,470,000USD-2,305,000USD-4,485,000USD-1,483,000USD
    Unclassified Investing Cash Flow—28,188,000USD—12,414,000USD13,340,000USD23,943,000USD6,715,000USD-163,865,000USD
    Change To Liabilities———-1,958,000USD-1,893,000USD251,000USD-8,870,000USD8,727,000USD
    Cash And Cash Equivalents Changes———-17,507,000USD-9,148,000USD———
    Dividends Paid————-3,756,000USD-4,758,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductOther Products2,289,000USD0001628280-26-032620
    Q1 2026Quarterly · 2026-03-31ProductPreservation Services24,895,000USD0001628280-26-032620
    Q1 2026Quarterly · 2026-03-31ProductProducts — Aortic Stent Grafts44,397,000USD0001628280-26-032620
    Q1 2026Quarterly · 2026-03-31ProductProducts — On X25,951,000USD0001628280-26-032620
    Q1 2026Quarterly · 2026-03-31ProductProducts — Surgical Sealants18,805,000USD0001628280-26-032620
    Q4 2025Quarterly · 2025-12-31ProductOther Products463,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductPreservation Services24,074,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProducts — Aortic Stent Grafts43,343,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProducts — On X27,797,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProducts — Surgical Sealants20,315,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductOther Products8,112,000USD0001628280-26-009046
    FY 2025Yearly · 2025-12-31ProductPreservation Services95,505,000USD0001628280-26-009046
    FY 2025Yearly · 2025-12-31ProductProducts — Aortic Stent Grafts159,371,000USD0001628280-26-009046
    FY 2025Yearly · 2025-12-31ProductProducts — On X101,740,000USD0001628280-26-009046
    FY 2025Yearly · 2025-12-31ProductProducts — Surgical Sealants76,602,000USD0001628280-26-009046
    Q3 2025Quarterly · 2025-09-30ProductOther Products2,390,000USD0001628280-25-050502
    Q3 2025Quarterly · 2025-09-30ProductPreservation Services25,723,000USD0001628280-25-050502
    Q3 2025Quarterly · 2025-09-30ProductProducts — Aortic Stent Grafts39,585,000USD0001628280-25-050502
    Q3 2025Quarterly · 2025-09-30ProductProducts — On X26,797,000USD0001628280-25-050502
    Q3 2025Quarterly · 2025-09-30ProductProducts — Surgical Sealants18,893,000USD0001628280-25-050502
    Q2 2025Quarterly · 2025-06-30ProductOther Products2,743,000USD0001628280-25-039166
    Q2 2025Quarterly · 2025-06-30ProductPreservation Services25,528,000USD0001628280-25-039166
    Q2 2025Quarterly · 2025-06-30ProductProducts — Aortic Stent Grafts39,841,000USD0001628280-25-039166
    Q2 2025Quarterly · 2025-06-30ProductProducts — On X25,572,000USD0001628280-25-039166
    Q2 2025Quarterly · 2025-06-30ProductProducts — Surgical Sealants19,288,000USD0001628280-25-039166
    Q1 2025Quarterly · 2025-03-31ProductOther Products2,516,000USD0001628280-26-032620
    Q1 2025Quarterly · 2025-03-31ProductPreservation Services20,180,000USD0001628280-26-032620
    Q1 2025Quarterly · 2025-03-31ProductProducts — Aortic Stent Grafts36,602,000USD0001628280-26-032620
    Q1 2025Quarterly · 2025-03-31ProductProducts — On X21,574,000USD0001628280-26-032620
    Q1 2025Quarterly · 2025-03-31ProductProducts — Surgical Sealants18,106,000USD0001628280-26-032620
    Q4 2024Quarterly · 2024-12-31ProductOther Products2,404,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductPreservation Services22,646,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProducts — Aortic Stent Grafts30,145,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProducts — On X22,178,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProducts — Surgical Sealants19,935,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductOther Products9,269,000USD0001628280-26-009046
    FY 2024Yearly · 2024-12-31ProductPreservation Services98,307,000USD0001628280-26-009046
    FY 2024Yearly · 2024-12-31ProductProducts — Aortic Stent Grafts123,081,000USD0001628280-26-009046
    FY 2024Yearly · 2024-12-31ProductProducts — On X83,982,000USD0001628280-26-009046
    FY 2024Yearly · 2024-12-31ProductProducts — Surgical Sealants73,898,000USD0001628280-26-009046
    Q3 2024Quarterly · 2024-09-30ProductOther Products2,686,000USD0001628280-25-050502
    Q3 2024Quarterly · 2024-09-30ProductPreservation Services24,535,000USD0001628280-25-050502
    Q3 2024Quarterly · 2024-09-30ProductProducts — Aortic Stent Grafts28,643,000USD0001628280-25-050502
    Q3 2024Quarterly · 2024-09-30ProductProducts — On X21,478,000USD0001628280-25-050502
    Q3 2024Quarterly · 2024-09-30ProductProducts — Surgical Sealants18,437,000USD0001628280-25-050502
    Q2 2024Quarterly · 2024-06-30ProductOther Products1,830,000USD0001628280-25-039166
    Q2 2024Quarterly · 2024-06-30ProductPreservation Services24,809,000USD0001628280-25-039166
    Q2 2024Quarterly · 2024-06-30ProductProducts — Aortic Stent Grafts32,190,000USD0001628280-25-039166
    Q2 2024Quarterly · 2024-06-30ProductProducts — On X20,645,000USD0001628280-25-039166
    Q2 2024Quarterly · 2024-06-30ProductProducts — Surgical Sealants18,545,000USD0001628280-25-039166
    FY 2023Yearly · 2023-12-31ProductOther Products11,172,000USD0001628280-26-009046
    FY 2023Yearly · 2023-12-31ProductPreservation Services92,819,000USD0001628280-26-009046
    FY 2023Yearly · 2023-12-31ProductProducts — Aortic Stent Grafts107,469,000USD0001628280-26-009046
    FY 2023Yearly · 2023-12-31ProductProducts — On X74,528,000USD0001628280-26-009046
    FY 2023Yearly · 2023-12-31ProductProducts — Surgical Sealants68,016,000USD0001628280-26-009046
    Q3 2023Quarterly · 2023-09-30SegmentMedical Devices63,747,000USD0000784199-23-000150
    Q3 2023Quarterly · 2023-09-30SegmentPreservation Services24,107,000USD0000784199-23-000150
    Q2 2023Quarterly · 2023-06-30SegmentMedical Devices66,003,000USD0000784199-23-000134
    Q2 2023Quarterly · 2023-06-30SegmentPreservation Services23,248,000USD0000784199-23-000134
    Q1 2023Quarterly · 2023-03-31SegmentMedical Devices62,291,000USD0000784199-23-000088
    Q1 2023Quarterly · 2023-03-31SegmentPreservation Services20,938,000USD0000784199-23-000088
    FY 2022Yearly · 2022-12-31ProductOther Products8,318,000USD0000784199-25-000029
    FY 2022Yearly · 2022-12-31ProductPreservation Services83,436,000USD0000784199-25-000029
    FY 2022Yearly · 2022-12-31ProductProducts — Aortic Stent Grafts92,752,000USD0000784199-25-000029
    FY 2022Yearly · 2022-12-31ProductProducts — On X63,904,000USD0000784199-25-000029
    FY 2022Yearly · 2022-12-31ProductProducts — Surgical Sealants65,379,000USD0000784199-25-000029
    Q4 2022Quarterly · 2022-12-31SegmentMedical Devices58,627,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentPreservation Services20,771,000USDLegacy provider
    FY 2022Yearly · 2022-12-31GeographyInternational152,676,000USD0000784199-23-000040
    FY 2022Yearly · 2022-12-31GeographyUnited States161,113,000USD0000784199-23-000040
    FY 2022Yearly · 2022-12-31SegmentMedical Devices230,353,000USD0000784199-23-000040
    FY 2022Yearly · 2022-12-31SegmentPreservation Services83,436,000USD0000784199-23-000040
    Q3 2022Quarterly · 2022-09-30SegmentMedical Devices55,248,000USD0000784199-23-000150
    Q3 2022Quarterly · 2022-09-30SegmentPreservation Services21,590,000USD0000784199-23-000150
    Q2 2022Quarterly · 2022-06-30SegmentMedical Devices58,936,000USD0000784199-23-000134
    Q2 2022Quarterly · 2022-06-30SegmentPreservation Services21,404,000USD0000784199-23-000134
    Q1 2022Quarterly · 2022-03-31SegmentMedical Devices57,542,000USD0000784199-23-000088
    Q1 2022Quarterly · 2022-03-31SegmentPreservation Services19,671,000USD0000784199-23-000088
    FY 2021Yearly · 2021-12-31ProductOther Products8,133,000USD0000784199-24-000033
    FY 2021Yearly · 2021-12-31ProductPreservation Services77,239,000USD0000784199-24-000033
    FY 2021Yearly · 2021-12-31ProductProducts — Aortic Stent Grafts85,387,000USD0000784199-24-000033
    FY 2021Yearly · 2021-12-31ProductProducts — On X57,363,000USD0000784199-24-000033
    FY 2021Yearly · 2021-12-31ProductProducts — Surgical Sealants70,714,000USD0000784199-24-000033
    Q4 2021Quarterly · 2021-12-31SegmentMedical Devices59,069,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31SegmentPreservation Services20,325,000USDLegacy provider
    FY 2021Yearly · 2021-12-31GeographyInternational147,685,000USD0000784199-23-000040
    FY 2021Yearly · 2021-12-31GeographyUnited States151,151,000USD0000784199-23-000040
    FY 2021Yearly · 2021-12-31SegmentMedical Devices221,597,000USD0000784199-23-000040
    FY 2021Yearly · 2021-12-31SegmentPreservation Services77,239,000USD0000784199-23-000040
    FY 2020Yearly · 2020-12-31ProductCardiogenesis464,000USD0000784199-22-000076
    FY 2020Yearly · 2020-12-31ProductDomestic Hospitals137,810,000USD0000784199-22-000076
    FY 2020Yearly · 2020-12-31ProductInternational Distributor34,429,000USD0000784199-22-000076
    FY 2020Yearly · 2020-12-31ProductInternational Hospitals80,524,000USD0000784199-22-000076
    FY 2020Yearly · 2020-12-31GeographyInternational114,953,000USD0000784199-23-000040
    FY 2020Yearly · 2020-12-31GeographyUnited States138,274,000USD0000784199-23-000040
    FY 2020Yearly · 2020-12-31SegmentMedical Devices179,299,000USD0000784199-23-000040
    FY 2020Yearly · 2020-12-31SegmentPreservation Services73,928,000USD0000784199-23-000040
    FY 2019Yearly · 2019-12-31ProductCardiogenesis6,016,000USD0000784199-22-000076
    FY 2019Yearly · 2019-12-31ProductDomestic Hospitals144,538,000USD0000784199-22-000076
    FY 2019Yearly · 2019-12-31ProductInternational Distributor40,427,000USD0000784199-22-000076

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.